Sandu Pharmaceuticals Ltd. Board Meeting Scheduled for August 11, Trading Window Closed Ahead of Q2 Results Review
Sandu Pharmaceuticals Ltd. has scheduled a meeting of its Board of Directors to review the company's standalone unaudited financial results for the quarter ended June 30, 2026.The Board meeting is set for Tuesday, August 11, 2026, at 4:00 p.m. The meeting will be held at the Corporate Office of Sandu Pharmaceuticals Limited located in Chembur, Mumbai.
The primary agenda item for the meeting is to consider and approve the Standalone Unaudited Financial Results of the Company for the quarter ended June 30, 2026. Directors and officers are also scheduled to discuss any other matter with the permission of the Chair.
In addition to the corporate review, the company has confirmed the closure of its trading window concerning the Securities of the Company. This restriction is in compliance with the Code of Conduct for prevention of Insider Trading.
The trading window for designated employees and Directors was closed starting from the opening of trading hours on Wednesday, July 1, 2026. The restriction remains in place until 48 hours following the announcement of financial results for the quarter ended June 30, 2026.
Stock Price Movement
With the market activity running through 15:30, shares of Sandu Pharmaceuticals are edging higher, currently trading at ₹40.69, representing a 4.23% increase. Throughout the day, the stock observed movement within an intraday range stretching from a low of ₹39.05 to a peak high of ₹40.92.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.